ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

septembre 4, 2019 0 Par admin

Translating…

SAN DIEGO–()–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New York City.

More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible for approximately 90 days following the conference.

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 120 countries. To learn more, visit ResMed.com and follow @ResMed.


Huile de CBD peut aider avec troubles de sommeil. Visite HuileCBD.be


 
Lire la suite